Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing’s disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://link.springer.com/content/pdf/10.1007/s11102-020-01097-1.pdf
Reference15 articles.
1. Lacroix A, Feelders RA, Stratakis CA, Nieman LK (2015) Cushing’s syndrome. Lancet 386(9996):913–927. https://doi.org/10.1016/s0140-6736(14)61375-1
2. Fleseriu M, Findling JW, Koch CA, Schlaffer SM, Buchfelder M, Gross C (2014) Changes in plasma ACTH levels and corticotroph tumor size in patients with Cushing’s disease during long-term treatment with the glucocorticoid receptor antagonist mifepristone. J Clin Endocrinol Metab 99(10):3718–3727. https://doi.org/10.1210/jc.2014-1843
3. Feelders RA, Newell-Price J, Pivonello R, Nieman LK, Hofland LJ, Lacroix A (2019) Advances in the medical treatment of Cushing’s syndrome. Lancet Diabetes Endocrinol 7(4):300–312. https://doi.org/10.1016/s2213-8587(18)30155-4
4. Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A (2015) Treatment of cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100(8):2807–2831. https://doi.org/10.1210/jc.2015-1818
5. Pivonello R, De Leo M, Cozzolino A, Colao A (2015) The treatment of cushing’s disease. Endocr Rev 36(4):385–486. https://doi.org/10.1210/er.2013-1048
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. From Nelson’s Syndrome to Corticotroph Tumor Progression Speed: An Update;Experimental and Clinical Endocrinology & Diabetes;2024-07-03
2. Medical treatment of functional pituitary adenomas, trials and tribulations;Journal of Neuro-Oncology;2024-05-18
3. Cushing’s Disease: Long-Term Effectiveness and Safety of Osilodrostat in a Polish Group of Patients with Persistent Hypercortisolemia in the Experience of a Single Center;Biomedicines;2023-12-06
4. An individualized approach to the management of Cushing disease;Nature Reviews Endocrinology;2023-08-03
5. Progression of a corticotroph tumour during durable medical therapy with osilodrostat in a patient with persistent Cushing’s disease;Endokrynologia Polska;2023-06-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3